BIOMARIN PHARMACEUTICAL INC (BMRN)
Pharmaceutical Preparations
Latest Price
$66.41
TTM P/E
170.28
Normalized P/E
56.38
Div Yield
--
Book Value
32.76
P/B Ratio
2.03
Valuation metrics
adjust assumptions →EPS: $1.80
Book value / share: $31.65
Formula: √(22.5 × EPS × BVPS)
Graham Number
$35.80
46% downside
Norm. op. income: $150M (median of 7yr)
Tax rate: 16%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$13.34
80% downside
Base FCF: $209M (median of recent 5yr)
Growth: 19%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$60.81
8% downside
EPS: $1.80
Target P/E: 56×
Formula: EPS × P/E
P/E Fair Value
$100.80
+52% upside
Institutional Ownership
99.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20.45M | $1.17B | 10.56% | +626.9K | 2026-06-30 |
| Dodge & Cox | 14.84M | $849.0M | 7.67% | +283.2K | 2026-06-30 |
| PRIMECAP MANAGEMENT CO/CA/ | 14.19M | $811.0M | 7.33% | -3.8K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.74M | $500.0M | 4.52% | +100.5K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.65M | $494.0M | 4.47% | +350.2K | 2026-06-30 |
| NORGES BANK | 8.21M | $469.0M | 4.24% | +676.9K | 2026-06-30 |
| STATE STREET CORP | 7.80M | $446.0M | 4.03% | +505.9K | 2026-06-30 |
| VIKING GLOBAL INVESTORS LP | 7.62M | $435.0M | 3.94% | +1.58M | 2026-06-30 |
| Vestal Point Capital, LP | 6.03M | $344.0M | 3.11% | +2.45M | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 5.70M | $322.0M | 2.94% | -1.98M | 2026-06-30 |